Novartis AG

Organization

Basel, CH

Ticker Symbols

NYSE:NVS

PHARMACEUTICAL PREPARATIONS
Business Address
LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
Mailing Address
LICHTSTRASSE 35 BASEL V8 CH 4056
State Location
V8
State of Incorporation
V8

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Means and method for producing and purifying viral vectors
- Patent number 12,168,777
- Issue date Dec 17, 2024
- Novartis AG
- Brian K. Kaspar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,168,012
- Issue date Dec 17, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
- Patent number 12,161,624
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic NMDA receptor modulators and uses thereof
- Patent number 12,162,890
- Issue date Dec 10, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Automatic drug delivery device
- Patent number 12,161,843
- Issue date Dec 10, 2024
- Novartis AG
- Jacques Appy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent targeting of E3 ligases
- Patent number 12,161,648
- Issue date Dec 10, 2024
- The Regents of the University of California
- Jessica Spradlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Enhanced antigen presenting ability of RNA car T cells by co-introd...
- Patent number 12,162,922
- Issue date Dec 10, 2024
- Novartis AG
- Yangbing Zhao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heteroaryl substituted spiropiperidinyl derivatives and pharmaceuti...
- Patent number 12,157,737
- Issue date Dec 3, 2024
- Novartis AG
- Mallesh Bushaboina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating dry eye disease using TNF alpha antagonists
- Patent number 12,146,187
- Issue date Nov 19, 2024
- Novartis AG
- Yunsheng He
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...
- Patent number 12,145,909
- Issue date Nov 19, 2024
- Novartis AG
- David R. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,139,471
- Issue date Nov 12, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process of manufacture of a compound for inhibiting the activity of...
- Patent number 12,138,262
- Issue date Nov 12, 2024
- Novartis AG
- Zhongbo Fei
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for treating conditions associated with...
- Patent number 12,134,611
- Issue date Nov 5, 2024
- Novartis AG
- Jason Katz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using chimeric antigen receptor and protein kin...
- Patent number 12,128,069
- Issue date Oct 29, 2024
- The Trustees of the University of Pennsylvania
- Steven M. Albelda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroquinazoline derivatives for the treatment of a disease or diso...
- Patent number 12,129,246
- Issue date Oct 29, 2024
- Novartis AG
- Daniela Angst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 12,122,761
- Issue date Oct 22, 2024
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and...
- Patent number 12,103,919
- Issue date Oct 1, 2024
- Novartis AG
- Simone Bonazzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy
- Patent number 12,090,125
- Issue date Sep 17, 2024
- Novartis AG
- Päivi M. Paldánius
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rapamycin derivatives
- Patent number 12,091,424
- Issue date Sep 17, 2024
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Drug delivery device
- Patent number D1042795
- Issue date Sep 17, 2024
- Sandoz AG
- Leon Rizner
- D24 - Medical and laboratory equipment
Information Patent Grant
Naphthyridinone derivatives for the treatment of a disease or disorder
- Patent number 12,084,442
- Issue date Sep 10, 2024
- Novartis AG
- Atwood Kim Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of a TLR7/TLR8 inhibitor
- Patent number 12,084,460
- Issue date Sep 10, 2024
- Novartis AG
- Nicole Bieri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for treating conditions associated with...
- Patent number 12,084,424
- Issue date Sep 10, 2024
- Novartis AG
- Luigi Franchi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiviral 1,3-di-oxo-indene compounds
- Patent number 12,083,092
- Issue date Sep 10, 2024
- Novartis AG
- Johan Neyts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhi...
- Patent number 12,083,101
- Issue date Sep 10, 2024
- Novartis AG
- Vincent Bordas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polyomavirus neutralizing antibodies
- Patent number 12,077,571
- Issue date Sep 3, 2024
- Novartis AG
- Johanna Abend
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-IL-17A antibodies and their use in treating autoimmune and inf...
- Patent number 12,077,580
- Issue date Sep 3, 2024
- Novartis AG
- Franco E. Di Padova
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunosuppressant formulations
- Patent number 12,071,402
- Issue date Aug 27, 2024
- Novartis AG
- Philippe Michel Rene Bouillot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,...
- Patent number 12,071,441
- Issue date Aug 27, 2024
- Novartis AG
- Maxime Dauphinais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD40 antibodies for use in treatment of Sjögren's syndrome
- Patent number 12,065,499
- Issue date Aug 20, 2024
- Novartis AG
- Pascal Espie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANT...
- Publication number 20240415961
- Publication date Dec 19, 2024
- Novartis AG
- Susanne JOERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
- Publication number 20240417722
- Publication date Dec 19, 2024
- Novartis AG
- Ming-Wei CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for the preparation of sucrose octasulfate octakistriethyla...
- Publication number 20240417417
- Publication date Dec 19, 2024
- SANDOZ AG
- Borut Zupancic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES
- Publication number 20240408206
- Publication date Dec 12, 2024
- Novartis AG
- Andrei Thomas-Tikhonenko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGE...
- Publication number 20240398913
- Publication date Dec 5, 2024
- Novartis AG
- David M. Barrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL TRANSCRIPTION FACTORS
- Publication number 20240398985
- Publication date Dec 5, 2024
- Novartis AG
- Keith Everett FERGUSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF FACTOR B INHIBITORS FOR THE TREATMENT OF AGE-RELATED MACULAR...
- Publication number 20240398779
- Publication date Dec 5, 2024
- Novartis AG
- Arnaud Armel Olivier CHARIL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
- Publication number 20240398798
- Publication date Dec 5, 2024
- Novartis AG
- Michaela Kneissel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A COMPUTER IMPLEMENTED METHOD FOR ASSESSING AND DETERMINING A COMPL...
- Publication number 20240404656
- Publication date Dec 5, 2024
- Novartis AG
- Naomi EBHOMIELEN
Information Patent Application
CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR
- Publication number 20240391938
- Publication date Nov 28, 2024
- Novartis AG
- Nicole BIERI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER
- Publication number 20240391941
- Publication date Nov 28, 2024
- Novartis AG
- Atwood CHEUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 AND CD22 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20240390492
- Publication date Nov 28, 2024
- Novartis AG
- Boris Engels
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...
- Publication number 20240391884
- Publication date Nov 28, 2024
- Novartis AG
- Luigi FRANCHI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION
- Publication number 20240384007
- Publication date Nov 21, 2024
- Novartis AG
- James E. Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER
- Publication number 20240382600
- Publication date Nov 21, 2024
- Novartis AG
- Emilie CHAPEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHI...
- Publication number 20240382457
- Publication date Nov 21, 2024
- Novartis AG
- Vincent BORDAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PS...
- Publication number 20240382631
- Publication date Nov 21, 2024
- Novartis AG
- Matthias EDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VIRAL VECTOR PRODUCTION SYSTEM
- Publication number 20240384293
- Publication date Nov 21, 2024
- Novartis AG
- Astrid Bosse
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE REC...
- Publication number 20240376099
- Publication date Nov 14, 2024
- Novartis AG
- Phillip Alper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A TEAD INHIBITOR AND USES TH...
- Publication number 20240374571
- Publication date Nov 14, 2024
- Novartis AG
- Emilie CHAPEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE
- Publication number 20240376094
- Publication date Nov 14, 2024
- LES LABORATOIRES SERVIER
- András Herner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND US...
- Publication number 20240366567
- Publication date Nov 7, 2024
- Novartis AG
- Saskia Maria BRACHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosing Regimen for a TEAD inhibitor
- Publication number 20240358720
- Publication date Oct 31, 2024
- Novartis AG
- Emilie CHAPEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS TARGETING PMP22 FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH...
- Publication number 20240360447
- Publication date Oct 31, 2024
- Novartis AG
- Charles ALLERSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYCLIN-DEPENDENT KINASE (CDK2) INHIBITORS
- Publication number 20240360137
- Publication date Oct 31, 2024
- Novartis AG
- Karin BRINER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFEC...
- Publication number 20240360082
- Publication date Oct 31, 2024
- Novartis AG
- Graham Charles BLOOMFIELD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic Compounds and their Uses
- Publication number 20240360118
- Publication date Oct 31, 2024
- Novartis AG
- Vincent BORDAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LOU064 FOR TREATING MULTIPLE SCLEROSIS
- Publication number 20240350489
- Publication date Oct 24, 2024
- Novartis AG
- Souvik BHATTACHARYA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF
- Publication number 20240352030
- Publication date Oct 24, 2024
- Novartis AG
- Cyrille Kounde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS...
- Publication number 20240350680
- Publication date Oct 24, 2024
- Novartis AG
- Matthias EDER
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
98912297
- Serial number 98912297
- Filing date Dec 19, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98912317
- Serial number 98912317
- Filing date Dec 19, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98827903 - HS HIDES IN THE SHADOWS
- Serial number 98827903
- Filing date Oct 30, 2024
- NOVARTIS AG
- 44 - Medical services
Information Trademark
98828714 - RHAPSIDO
- Serial number 98828714
- Filing date Oct 30, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98827896 - SHINE A LIGHT ON HS
- Serial number 98827896
- Filing date Oct 30, 2024
- NOVARTIS AG
- 44 - Medical services
Information Trademark
79411050 - STOQUEPT
- Serial number 79411050
- Filing date Oct 17, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411051 - STEZYLDA
- Serial number 79411051
- Filing date Oct 16, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411104 - ERELZI
- Serial number 79411104
- Filing date Oct 15, 2024
- Sandoz AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411435 - ZISGOTU
- Serial number 79411435
- Filing date Oct 14, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411252
- Serial number 79411252
- Filing date Sep 12, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411249
- Serial number 79411249
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410089 - KWAVRIS
- Serial number 79410089
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410090 - SVIQLA
- Serial number 79410090
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410124 - NAKVAE
- Serial number 79410124
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410121 - SJADVA
- Serial number 79410121
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410249 - SVIQAVI
- Serial number 79410249
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410091 - JSETRI
- Serial number 79410091
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410092 - KVARZA
- Serial number 79410092
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410122 - QATYERA
- Serial number 79410122
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411460
- Serial number 79411460
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410620 - CYJATTA
- Serial number 79410620
- Filing date Sep 11, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79411250
- Serial number 79411250
- Filing date Sep 10, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410123 - SKAAPRI
- Serial number 79410123
- Filing date Sep 10, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410125 - SYJASA
- Serial number 79410125
- Filing date Sep 10, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79410585
- Serial number 79410585
- Filing date Sep 3, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79408761 - CLEARTWIST
- Serial number 79408761
- Filing date Sep 3, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79408390 - VURJOR
- Serial number 79408390
- Filing date Aug 29, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79408334 - VYFREA
- Serial number 79408334
- Filing date Aug 29, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79408344 - TYLLIGO
- Serial number 79408344
- Filing date Aug 29, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
79407703 - VEMPRINEL
- Serial number 79407703
- Filing date Aug 29, 2024
- NOVARTIS AG
- 5 - Pharmaceutical and veterinary preparations

Novartis AG

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Means and method for producing and purifying viral vectors

NLRP3 inflammasome inhibitors

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Heteroaromatic NMDA receptor modulators and uses thereof

Automatic drug delivery device

Covalent targeting of E3 ligases

Enhanced antigen presenting ability of RNA car T cells by co-introd...

Heteroaryl substituted spiropiperidinyl derivatives and pharmaceuti...

Methods of treating dry eye disease using TNF alpha antagonists

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allos...

NLRP3 inflammasome inhibitors

Process of manufacture of a compound for inhibiting the activity of...

Compounds and compositions for treating conditions associated with...

Treatment of cancer using chimeric antigen receptor and protein kin...

Hydroquinazoline derivatives for the treatment of a disease or diso...

2-azaspiro[3.4]octane derivatives as M4 agonists

3-(5-oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and...

Combination therapy

Rapamycin derivatives

Drug delivery device

Naphthyridinone derivatives for the treatment of a disease or disorder

Crystalline forms of a TLR7/TLR8 inhibitor

Compounds and compositions for treating conditions associated with...

Antiviral 1,3-di-oxo-indene compounds

Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhi...

Polyomavirus neutralizing antibodies

Anti-IL-17A antibodies and their use in treating autoimmune and inf...

Immunosuppressant formulations

10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,...

Anti-CD40 antibodies for use in treatment of Sjögren's syndrome

Patents Applicationslast 30 patents

PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANT...

COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY

Process for the preparation of sucrose octasulfate octakistriethyla...

COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES

METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGE...

NOVEL TRANSCRIPTION FACTORS

USE OF FACTOR B INHIBITORS FOR THE TREATMENT OF AGE-RELATED MACULAR...

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

A COMPUTER IMPLEMENTED METHOD FOR ASSESSING AND DETERMINING A COMPL...

CRYSTALLINE FORMS OF A TLR7/TLR8 INHIBITOR

NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER

CD19 AND CD22 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

BIFUNCTIONAL DEGRADERS COMPRISING A TEAD BINDER

BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHI...

USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PS...

VIRAL VECTOR PRODUCTION SYSTEM

COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE REC...

PHARMACEUTICAL COMBINATIONS COMPRISING A TEAD INHIBITOR AND USES TH...

SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE

PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND US...

Dosing Regimen for a TEAD inhibitor

COMPOUNDS TARGETING PMP22 FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH...

CYCLIN-DEPENDENT KINASE (CDK2) INHIBITORS

SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFEC...

Bicyclic Compounds and their Uses

LOU064 FOR TREATING MULTIPLE SCLEROSIS

N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF

LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS...

Trademarklast 30 trademarks

98912297

98912317

98827903 - HS HIDES IN THE SHADOWS

98828714 - RHAPSIDO

98827896 - SHINE A LIGHT ON HS

79411050 - STOQUEPT

79411051 - STEZYLDA

79411104 - ERELZI

79411435 - ZISGOTU

79411252